Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheet

v2.4.0.8
Condensed Balance Sheet (USD $)
Jun. 30, 2014
Dec. 31, 2013
Current Assets:    
Cash and cash equivalents $ 38,104,488 $ 18,688,031
Marketable securities (note 3) 100,000 100,000
Prepaid expenses and other current assets (note 4) 901,297 507,165
Total Current Assets 39,105,785 19,295,196
Restricted Cash Equivalents (note 14) 78,156 196,130
Equipment, Net (note 5) 60,712 65,172
Total Assets 39,244,653 19,556,498
Current Liabilities:    
Accounts payable and accrued expenses (note 6) 1,539,851 933,758
Deferred Research and Development Arrangements (note 7) 678,156 833,630
Other Liabilities (note 8) 134,466 129,564
Warrant Liabilities (note 12) 6,583,403 5,034,058
Total Liabilities 8,935,876 6,931,010
Commitments and Contingencies (note 14)      
Stockholders' Equity (note 10):    
Preferred stock, par value $0.0001, 100,000,000 authorized shares, none issued and outstanding      
Common stock, par value $0.0001, 500,000,000 authorized shares, 178,266,533 and 146,732,000 issued and 178,153,318 and 146,717,795 outstanding 17,827 14,673
Additional paid-in capital 117,636,102 85,449,932
Accumulated deficit (87,216,742) (72,810,707)
Treasury stock, 113,215 and 14,205 shares, at cost (128,410) (28,410)
Total Stockholders' Equity 30,308,777 12,625,488
Total Liabilities and Stockholders' Equity $ 39,244,653 $ 19,556,498